Published in Int J Clin Pharmacol Ther on August 01, 2012
Mobile applications for diabetics: a systematic review and expert-based usability evaluation considering the special requirements of diabetes patients age 50 years or older. J Med Internet Res (2014) 2.03
Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry. Clin Res Cardiol (2011) 1.58
Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens (2004) 1.48
High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens (2004) 1.43
Drug interactions with angiotensin receptor blockers. Expert Opin Drug Saf (2005) 1.41
Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit (2005) 1.26
Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension. Vasc Health Risk Manag (2009) 1.22
Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter? Eur Heart J (2008) 1.10
Grapefruit juice ingestion significantly reduces talinolol bioavailability. Clin Pharmacol Ther (2005) 1.09
Simultaneous determination of three anticonvulsants using hydrophilic interaction LC-MS. J Sep Sci (2009) 1.07
Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents. JAMA (2009) 1.00
Clinical practice and recent recommendations in hypertension management--reporting a gap in a global survey of 1259 primary care physicians in 17 countries. Curr Med Res Opin (2007) 1.00
Effects of sertraline on autonomic and cognitive functions in healthy volunteers. Psychopharmacology (Berl) (2003) 0.99
[Antimicrobial and clinical efficacy of nitrofurantoin in the treatment of acute lower urinary tract infections in adults]. Med Klin (Munich) (2010) 0.95
Potential role of flavonoids in the prevention of intestinal neoplasia: a review of their mode of action and their clinical perspectives. Int J Gastrointest Cancer (2005) 0.94
Obesity and the risk for mental disorders in a representative German adult sample. Eur J Public Health (2006) 0.93
Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy. Vasc Health Risk Manag (2007) 0.93
Blood pressure management in a cohort of hypertensive patients in Germany treated by cardiologists. Clin Res Cardiol (2011) 0.93
Acceptance factors of mobile apps for diabetes by patients aged 50 or older: a qualitative study. Med 2 0 (2015) 0.92
Asymptomatic statin-induced rhabdomyolysis after long-term therapy with the hydrophilic drug pravastatin. Clin Ther (2007) 0.92
Laparoscopic or open conventional cholecystectomy: clinical and economic considerations. Eur J Surg (2002) 0.92
Effects of caffeine on topographic quantitative EEG. Neuropsychobiology (2002) 0.92
Potentially inappropriate prescribing for elderly outpatients in Germany: a retrospective claims data analysis. Int J Clin Pharmacol Ther (2012) 0.91
Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence. World J Gastroenterol (2008) 0.91
Atrial fibrillation management, outcomes and predictors of stable disease in daily practice: prospective non-interventional study. Int J Cardiol (2012) 0.90
Prescriptions of systemic antibiotics for children in Germany aged between 0 and 6 years. Pharmacoepidemiol Drug Saf (2003) 0.89
Albuminuria: pathophysiology, epidemiology and clinical relevance of an emerging marker for cardiovascular disease. Future Cardiol (2007) 0.88
Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registry. BMC Public Health (2009) 0.87
The effects of bupropion on heart rate variability in healthy volunteers. J Clin Psychopharmacol (2005) 0.86
Outpatient care and medical treatment of children and adults with atopic eczema. J Dtsch Dermatol Ges (2008) 0.84
[DRG Introduction in Germany. Options for action of hospitals]. Med Klin (Munich) (2005) 0.84
HYDRA: possible determinants of unsatisfactory hypertension control in German primary care patients. Blood Press (2004) 0.83
Use of abciximab and tirofiban in patients with peripheral arterial occlusive disease and arterial thrombosis. Angiology (2003) 0.83
Current pharmacotherapeutic concepts for the treatment of obesity in adults. Ther Adv Cardiovasc Dis (2008) 0.83
The effects of bupropion on cognitive functions in healthy subjects. Psychopharmacology (Berl) (2005) 0.82
Interaction between simvastatin and metoprolol with respect to cardiac beta-adrenoceptor density, catecholamine levels and perioperative catecholamine requirements in cardiac surgery patients. Naunyn Schmiedebergs Arch Pharmacol (2005) 0.81
Comparison of inhibitory effects of irbesartan and atorvastatin treatment on the renin angiotensin system (RAS) in veins: a randomized double-blind crossover trial in healthy subjects. J Clin Pharmacol (2007) 0.81
Managing hypertension among nursing-home residents and community-dwelling elderly in Germany: a comparative pharmacoepidemiological study. Eur J Clin Pharmacol (2011) 0.81
Antihypertensive effect of irbesartan and predictors of response in obesity-associated hypertension : a prospective, open-label study. Clin Drug Investig (2005) 0.79
Pharmacokinetic/pharmacodynamic modelling of venlafaxine: pupillary light reflex as a test system for noradrenergic effects. Clin Pharmacokinet (2008) 0.79
Mechanisms of beta-adrenergic receptor-mediated venodilation in humans. Clin Pharmacol Ther (2004) 0.79
The effects of lorazepam on skin conductance responses to aversive stimuli in healthy subjects. Clin Auton Res (2007) 0.79
[Colorectal cancer prevention by flavonoids]. Med Klin (Munich) (2010) 0.79
Performance of different data sources in identifying adverse drug events in hospitalized patients. Eur J Clin Pharmacol (2011) 0.79
Gender differences in patients with atrial fibrillation. Herzschrittmacherther Elektrophysiol (2013) 0.79
First patient-centered drug information service in Germany--a descriptive study. Ann Pharmacother (2004) 0.78
Drug information for patients--an update of long-term results: type of enquiries and patient characteristics. Pharmacoepidemiol Drug Saf (2009) 0.78
Pharmaco-economic impact of demographic change on pharmaceutical expenses in Germany and France. BMC Public Health (2012) 0.78
Frequency of albuminuria in primary care: a cross-sectional study. Eur J Cardiovasc Prev Rehabil (2007) 0.78
Burden of diabetes in the adult Chinese population: A systematic literature review and future projections. Int J Gen Med (2010) 0.78
[The use of guidelines in the primary care management of hypertension and diabetes]. Soz Praventivmed (2004) 0.78
Oral health-related quality of life and oral status in a German working population. Eur J Oral Sci (2011) 0.78
Characterization of local vascular effects of the nitric oxide inhibitor NG-monomethyl-L-arginine on dorsal hand veins. J Clin Pharmacol (2011) 0.78
[6-year experience with a drug information service for patients]. Med Klin (Munich) (2009) 0.78
Validation of a transparent decision model to rate drug interactions. BMC Pharmacol Toxicol (2012) 0.77
[Prevention of cardiovascular disease by blocking the endocannabinoid system]. Herz (2007) 0.77
Early exposure to antibiotics and infections and the incidence of atopic eczema: a population-based cohort study. Pediatr Allergy Immunol (2009) 0.77
Drug use patterns in young German women and association with mental disorders. Ann Pharmacother (2004) 0.77
Cardiovascular risk in obese hypertensive patients taking various antihypertensive drugs. Clin Drug Investig (2007) 0.77
The effects of venlafaxine on autonomic functions in healthy volunteers. J Clin Psychopharmacol (2007) 0.77
Influence of a fat-rich meal on bioavailability of extended-release and immediate-release propiverine. J Clin Pharmacol (2011) 0.77
The effects of St. John's wort extract and amitriptyline on autonomic responses of blood vessels and sweat glands in healthy volunteers. J Clin Psychopharmacol (2004) 0.77
Presentation of atrial fibrillation and its management by cardiologists in the ambulatory and hospital setting: MOVE cross-sectional study. Curr Med Res Opin (2011) 0.76
Extent and time course of pain intensity upon treatment with a topical diclofenac sodium patch versus placebo in acute traumatic injury based on a validated end point: post hoc analysis of a randomized placebo-controlled trial. Expert Opin Pharmacother (2010) 0.76
Disparities of conjugating protective enzyme activities in the colon of patients with adenomas and carcinomas. World J Gastroenterol (2013) 0.76
Treatment of neurological autoimmune diseases with immunoglobulins: first insights from the prospective SIGNS registry. J Clin Immunol (2012) 0.76
A tale of two Germanys: East Germany's health system provides lessons 14 years on. BMJ (2005) 0.75
[Treatment of plaque psoriasis with biologics. A meta-analysis of randomized controlled trials]. Med Klin (Munich) (2009) 0.75
[Socioeconomic relevance of the idiopathic restless legs syndrome (RLS) in Germany: cost-of-illness study]. Med Klin (Munich) (2009) 0.75
Determination of the novel melatonin agonist Neu-P11 in plasma samples by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal (2012) 0.75
[Drug information centers-instruments for health care research?]. Med Klin (Munich) (2005) 0.75
Pharmacokinetics and pharmacodynamics of calcium-vitamin D(3) chewable tablets: a single-blind, multiple-dose study in postmenopausal women. Expert Opin Drug Metab Toxicol (2011) 0.75
[Chlorambucil treatment of Behçet's syndrome. Retrospective evaluation of two cases]. Med Klin (Munich) (2010) 0.75
Determination of clindamycin and its metabolite clindamycin sulfoxide in diverse sewage samples. Environ Sci Pollut Res Int (2013) 0.75
Efficacy and tolerability of oral lactoferrin supplementation in mild to moderate acne vulgaris: an exploratory study. Curr Med Res Opin (2011) 0.75
[Prevention and law. The legal regulation of prevention in health care]. Med Klin (Munich) (2009) 0.75
Management of patients with atrial fibrillation by primary-care physicians in Germany: 1-year results of the ATRIUM registry. Clin Cardiol (2014) 0.75
Sensory symptoms in Behçet's syndrome. Adv Exp Med Biol (2003) 0.75
[What are the are the adverse health effects of sweeteners?]. Med Monatsschr Pharm (2012) 0.75
[Health care services research]. Med Klin (Munich) (2005) 0.75
[Risks associated with drug therapy. What do patients need to know? What can they do]. Med Klin (Munich) (2009) 0.75
Effects of the introduction of the German "Praxisgebühr" on outpatient care and treatment of patients with atopic eczema. J Dtsch Dermatol Ges (2009) 0.75
[Deinstitutionalization of psychiatric patients in Saxony: the beginning has been accomplished]. Pflege Z (2003) 0.75
[Memorandum III "methods for health services research", Part 1 [authors: H. Pfaff, G. Glaeske, E. A. M. Neugebauer, M. Schrappe] and Part 2 [authors: E. A. M. Neugebauer, A. Icks, M. Schrappe] of the Deutsches Netzwerk Versorgungsforschung e.V.: A summary]. Med Klin (Munich) (2011) 0.75
Early prevention of obesity and cardiovascular diseases. Dtsch Med Wochenschr (2002) 0.75
[Psychosomatic aspects of cardiac arrhythmias]. Med Klin (Munich) (2010) 0.75
[Health services research in Germany--status quo in the field of oral health]. Med Klin (Munich) (2005) 0.75
Evaluation of a program of integrated care to reduce recurrent osteoporotic fractures. Pharmacoepidemiol Drug Saf (2013) 0.75
[Current status of antihypertensive drug treatment in primary care practice at launch of the new renin inhibitor aliskiren (RASANT)]. Med Klin (Munich) (2010) 0.75
[Cost-effectiveness evaluation of drugs: multidisciplinary collaboration and transparency are key]. Med Klin (Munich) (2008) 0.75
[Antihypertensive drug utilization in obese patients]. Med Klin (Munich) (2005) 0.75
[Registries for clinical trials -- a critical stock-taking]. Med Klin (Munich) (2006) 0.75
Reoccurrence of levofloxacin-induced tendinitis by phenoxymethylpenicillin therapy after 6 months: a rare complication of fluoroquinolone therapy? Chemotherapy (2003) 0.75